Annals of Vascular Surgery · May 19, 2026

Predicting Survival for Patients Turned down for Elective Abdominal Aortic Aneurysm Repair: Results of a UK Study and the Effectiveness of the CHA₂DS₂-VASc Score

By Hamid K, Dhahri AA, Rao A et al.

BACKGROUND: National registries report on procedures and outcomes for patients with abdominal aortic aneurysms (AAAs) leaving the outcomes of patients who do not undergo surgery undefined. This study aimed to determine survival of patients who do not undergo or decline intervention, termed 'turned down' for AAA repair, and evaluate the CHA₂DS₂-VASc score as a predictor of mortality. METHODS: Prospectively collected data were analyzed on all patients turned down for elective AAA repair within a large tertiary vascular network in England between 2016 and 2024. Demographic, clinical, and aneurysm characteristics were recorded, and CHA₂DS₂-VASc score was calculated for each patient. Kaplan-Meier survival analysis and Cox regression were used to assess long-term survival and identify predictors of mortality. RESULTS: Of 1,181 patients with infrarenal AAA referred for repair, 286 (24.2%) were declined intervention. The mean age at turndown was 83 years, and 69% were male. Mean AAA diameter at turndown was 6.0 cm. One-, 3-, and 5-year survival rates were 74%, 19%, and 5%, respectively. Increasing aneurysm size was significantly associated with AAA-related mortality. Age and higher CHA₂DS₂-VASc scores were independently associated with reduced survival at 3 years (P = 0.001 and P = 0.05, respectively) CONCLUSION: Patients with AAA who are turned down for repair exhibit high early mortality, a reflection of advanced age, frailty, and comorbidity. The CHA₂DS₂-VASc score serves as a simple and practical tool to predict survival. These findings highlight the need for follow-up and ideally registry inclusion of nonoperated patients to help predict outcomes and enable shared decision-making with patients.

doi.org/10.1016/j.avsg.2026.04.070PubMed 42162862Biomarkers

AgingResearch.News